Terfenadine off the market
February 1997
The FDA is trying to take terfenadine off the market...Seldane, Seldane-D, and the new generics from Rugby and Zenith.
There have been hundreds of reports of arrhythmias and sudden death associated with terfenadine. The FDA says it's no longer worth the risk...now that Allegra is on the market.
Allegra (fexofenadine) is the active metabolite of terfenadine...it's just as effective, but without the risk.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote